vasopressin receptor

The V1a vasopressin receptor gene is a mechanism most widely studied.

Mutations in the vasopressin receptor cause a similar X-linked phenotype.

Gene variations for the vasopressin receptor could be a factor for fidelity.

Tolvaptan - an antagonist of the V vasopressin receptor.

Hyponatremia can be treated pharmaceutically through the use of vasopressin receptor antagonists.

Arginine vasopressin receptor 1A is also known as:

Polygamous Voles have a significantly smaller number of vasopressin receptors and remain shy even after mating.

This is the gene for the vasopressin receptor, the device used by neurons to respond to vasopressin.

Arginine vasopressin receptor 2 is also expressed in the DCT.

Vasopressin receptor antagonists that are selective for the V2 receptor include:

This increase correlates with increase is vasopressin receptors in this area of the paternal brain.

However, in theory, vasopressin receptor antagonism would be particularly useful in this setting, and an initial study shows that it has some promise.

Desmopressin is used to improve platelet function by activating arginine vasopressin receptor 1A.

Conivaptan - an antagonist of both V and V vasopressin receptors.

C1QTNF1 has been shown to interact with Arginine vasopressin receptor 2.

Therefore, it is alteration of vasopressin receptor gene expression patterns is thought to affect social behavior, rather than the neuropeptide itself.

Conivaptan inhibits two of the three subtypes of the vasopressin receptor (V1a and V2).

The vasopressin receptor antagonists, dubbed vaptans, target the vasopressin hormonal feedback system.

The difference is the presence of a certain gene, the vasopressin receptor, found in the ventral pallium, one of the brain's pleasure and reward centers.

Mozavaptan (INN) is a vasopressin receptor antagonist marketed by Otsuka.

Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1a subtype.

Voles with long and short DNA segments had different patterns of vasopressin receptors in their brains, which presumably changed their response to the hormone.

A vasopressin receptor antagonist is an agent that interferes with the action at the vasopressin receptors.

L-368,899 is a drug used in scientific research which acts as a selective antagonist of the oxytocin receptor, with good selectivity over the related vasopressin receptors.

Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As.